Entinostat
Drug timelines are a Plus or Pro feature.
40 regulatory and trial events tracked for Entinostat, covering 2013-09-19 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer [Phase 1]